← Journal
Day 76 Bioelectricity · Ecology · The Ecosystem Masterpiece edition · 14 min read

The Microbiome: The Ecosystem That Lives in You

Yesterday a cell remembered what it is by writing marks on its own DNA. But here is the twist that ends this arc: some of those marks are written by molecules your bacteria make. Because you are not one organism. There is a number for how alone you are inside your own skin, and it is roughly zero — for every human cell you carry, you carry about one bacterial cell, some thirty-odd trillion of each. They live on your skin and in your mouth and, in overwhelming density, in your gut. They digest food you cannot, train an immune system that would misfire without them, manufacture vitamins your own cells never learned to make, and — the thread that ties this whole season together — produce a compound that reaches up and changes how your genes are read. In a real, countable sense you are a walking rainforest: a body that is also a habitat.

The microbiome — a luminous teeming ecosystem of microbial life, glowing bacterial colonies in cyan and violet threaded through a landscape of light
Bioelectricity · Ecology · The Ecosystem

The number everyone got wrong

For decades, the fact everyone repeated was that microbial cells outnumber human cells ten to one — that you are, in some unsettling accounting, only ten percent human. It is a wonderful line. It is also wrong. In 2016, Ron Sender, Shai Fuchs, and Ron Milo went back through the actual measurements and rebuilt the estimate from the ground up.[1] Their answer, for a reference adult: roughly 38 trillion bacteria to roughly 30 trillion human cells — a ratio close to one to one, not ten to one. All those bacteria together weigh only about 0.2 kilograms. The famous 10:1 turned out to trace back to a single back-of-the-envelope estimate from the 1970s, repeated so often it hardened into a fact. The correction is the story in miniature: the microbiome is astonishing enough that it never needed the exaggeration.

And the correction, its authors insisted, takes nothing away. Even at one to one, the microbial contribution is staggering where it counts — in the genes. Your own genome carries around 20,000 protein-coding genes. The collective microbiome carries millions. When the MetaHIT consortium sequenced the gut community of 124 people in 2010, it catalogued 3.3 million non-redundant microbial genes — on the order of a hundred and fifty times the human count — from roughly a thousand bacterial species.[2] This is why the microbiome is often called your "second genome": a vast, metabolically active library of capabilities your own DNA never had to encode, because your tenants encode them for you.

This B/H value of about 1:1… should replace the 10:1 or 100:1 values that are stated in the literature. — Sender, Fuchs & Milo, PLoS Biology (2016)
~1 : 1bacteria to human cells (not 10:1)
~3.3 millionmicrobial genes catalogued (gut)
~0.2 kgtotal weight of your bacteria

What the ecosystem does — and the molecule that writes on your genes

The community is not a passenger; it is an organ you were not born with and assembled after birth. Its densest, most consequential work happens in the colon, where the great majority of your bacteria live (the stomach and upper small intestine, acidic and fast-moving, hold very few). There, microbes do something your own body cannot: they ferment dietary fiber — the plant matter your enzymes cannot break down — into short-chain fatty acids, principally butyrate, propionate, and acetate.[3] Butyrate is the preferred fuel of the cells lining your colon; a meaningful fraction of that tissue's energy is quite literally supplied by its bacteria.

And here the season closes its loop. Butyrate is not only fuel — it is also a histone-deacetylase inhibitor.[3] Recall from yesterday that histone-modifying enzymes tune whether chromatin is open or closed. HDAC enzymes remove acetyl tags, tightening the packing and quieting genes; by inhibiting them, butyrate tips the balance the other way — toward a more open, acetylated, transcriptionally active state. That is a genuine epigenetic effect — except the molecule doing the writing was manufactured by your microbes, from your dinner. It is the cleanest possible bridge from Day 75: a compound made by your bacteria can change how your own genes are read. (Keep the claim modest and mechanistic — much of the direct evidence is from cell and model systems — but the link is real.) Beyond that, the microbiome trains the immune system, synthesizes vitamins like K and several B vitamins, and provides colonization resistance — a balanced community crowds out invaders. Which is exactly what fails, catastrophically, when antibiotics clear the field and let a pathogen bloom.

From animalcules to the one proven cure

We have known these tenants exist for almost three and a half centuries. In 1683, the Delft draper Antonie van Leeuwenhoek, peering through his own single-lens microscopes, scraped the plaque from his teeth and reported to the Royal Society the "little animalcules" swimming in it — the first human sighting of bacteria.[4] Two centuries later, the Nobel immunologist Élie Metchnikoff proposed in 1907 that the lactic-acid bacteria in fermented milk could suppress "intestinal putrefaction" and extend life, pointing to long-lived Bulgarian yogurt-eaters. He was half right in a way that still shapes this field: he over-speculated wildly on the longevity mechanism, which did not hold up — yet he correctly intuited that gut bacteria matter to health, making him the ancestor of both real microbiome science and the probiotic marketing that overreached. In 2007, the U.S. National Institutes of Health launched the Human Microbiome Project to map, systematically, the microbial communities of healthy people across five body sites — the moment the field grew into big science.

And it produced exactly one clearly proven therapy — which is the whole honest point. In 2013, a randomized trial by Els van Nood and colleagues tested fecal microbiota transplantation — restoring a healthy donor's microbial community — against standard antibiotics for recurrent Clostridioides difficile infection, the miserable gut infection that takes hold precisely when antibiotics have wrecked colonization resistance. The result was so decisive the trial was stopped early: 81% of patients resolved after a single infusion, versus 31% on vancomycin alone.[5] The principle — restore the ecosystem, cure the disease — was proven. It has since matured into FDA-approved products: Rebyota (2022) and the first oral one, Vowst (2023).[6] Note what makes it real medicine: it is specific — matched to a defined infection — effective, and regulated. That specificity is the yardstick against which every other "gut health" promise should be measured.

  1. Step 1 · The tenantsTrillions of microbes, densest in the colon~38 trillion bacteria (plus archaea, fungi, viruses) live in and on you, overwhelmingly in the large intestine.[1]
  2. Step 2 · FermentationFiber becomes short-chain fatty acidsGut microbes ferment dietary fiber your own enzymes cannot digest into butyrate, propionate, and acetate.[3]
  3. Step 3 · SignalButyrate feeds cells and writes on genesButyrate fuels colon cells and acts as an HDAC inhibitor — a microbial molecule with a genuine epigenetic effect (the Day-75 bridge). Microbes also make vitamins K and B.
  4. Step 4 · DefenseColonization resistanceA balanced community crowds out pathogens and helps train the immune system — a barrier antibiotics can breach.
  5. Step 5 · Disruption & repairDysbiosis — and the one proven cureA disrupted community is associated with many diseases; in the one clearly proven case, restoring it with FMT cures recurrent C. difficile.[5]

The honest ledger — real, vast, and wildly oversold

Here the discipline of this Journal earns its keep, because few areas of biology are as real and as overhyped at once. Established, plainly: the microbiome exists and is vast; the ratio is about one to one, not ten to one; it carries millions of genes to your twenty thousand; it ferments fiber into short-chain fatty acids, with butyrate fueling colon cells and acting as an HDAC inhibitor; it trains immunity, makes some vitamins, and resists pathogens; and dysbiosis — a disrupted community — is associated with many conditions, from inflammatory bowel disease to obesity. And FMT for recurrent C. difficile is a real, effective, regulated therapy. That is a lot of solid ground.

The frontier is where care is mandatory. The microbiome's causal role in obesity, metabolic disease, autoimmunity, and mood — the gut–brain axis — is supported by striking associations and compelling animal work, but causation in humans is largely unproven. Microbiome therapies beyond recurrent C. diff are investigational. Diet reshapes the microbiome, but the effects are highly individual, and personalized-nutrition claims outrun the data. Whether a given probiotic strain helps a given condition is strain- and indication-specific, not a class effect. Keep every one of these sentences in the conditional, because the science does.

And then the overreach, named without apology. The broad probiotic and "gut health" supplement industry is marketed as a cure-all; the American Gastroenterological Association concluded in 2020 that the evidence is insufficient to recommend probiotics for most digestive conditions, with benefit only in a few narrow settings.[6] "Gut reset," "cleanse," and "detox" products are marketing language, not physiology. And direct-to-consumer microbiome-testing kits, sold as actionable personal health guidance, are largely not clinically validated — a 2025 analysis found results vary between providers on a scale comparable to the biological differences between different people, and they are not diagnostics.[6] The tell is the one FMT teaches: real microbiome medicine is specific, matched to a defined problem, and regulated. A product that promises to "reset your gut" and fix everything at once is selling the opposite of how the one proven therapy actually works.

The careful 2026 reading

Established: the microbiome — bacteria (the vast majority), plus archaea, fungi, viruses — is vast (~38 trillion bacteria, ~0.2 kg) in a body of ~30 trillion human cells; the ratio is ~1:1, NOT the debunked 10:1 (Sender, Fuchs & Milo 2016). Millions of microbial genes vs. ~20,000 human genes — the "second genome"; ~1,000 gut species; MetaHIT catalogued 3.3 million genes (Qin 2010). Gut microbes ferment fiber into short-chain fatty acids (butyrate/propionate/acetate); butyrate fuels colonocytes AND is an HDAC INHIBITOR — a genuine epigenetic effect (the Day-75 bridge). The microbiome trains immunity, makes some vitamins (K, B), and provides colonization resistance. Dysbiosis is ASSOCIATED with many diseases (IBD, obesity, metabolic). FMT for recurrent C. difficile is real, effective, and FDA-regulated (van Nood 2013, 81% resolution; Rebyota 2022; Vowst 2023) — the single clearest proven microbiome therapy. History: Leeuwenhoek's "animalcules" (1683); Metchnikoff (1907, over-speculated); NIH Human Microbiome Project (2007). Frontier (real, unsettled, mostly association in humans): causal roles in obesity, metabolic and autoimmune disease, and mood (gut–brain axis); therapies beyond C. diff; individualized diet effects; strain-specific probiotic benefit. Rejected / overclaimed: probiotic/"gut health" cure-alls (AGA 2020: insufficient evidence for most conditions); "gut reset"/"cleanse"/"detox" (marketing, not physiology); direct-to-consumer microbiome tests as personal health guidance (not validated diagnostics; results vary by lab). Real microbiome medicine is specific, matched, and regulated. Most disease links are association, not causation. Tesla BioLights makes no medical claims.

Quick answers

What is the microbiome?

The community of microorganisms — overwhelmingly bacteria, plus archaea, fungi, and viruses — living in and on the body, together with their genes. It is present at many sites but densest by far in the colon. It helps digest food, trains immunity, and makes molecules your own cells cannot — in a countable sense, a body that is also a habitat.

Do microbes really outnumber human cells 10 to 1?

No — that is a corrected myth. A careful 2016 re-estimate (Sender, Fuchs & Milo) put it at about 38 trillion bacteria to about 30 trillion human cells — roughly 1:1 — weighing only about 0.2 kg. The old 10:1 came from a single 1970s back-of-the-envelope figure repeated as fact. The correction doesn't diminish the microbiome's importance.

What does the gut microbiome do?

It ferments dietary fiber into short-chain fatty acids (butyrate, propionate, acetate — butyrate fuels colon cells), trains and regulates immunity, synthesizes some vitamins (K, several B), and provides colonization resistance against pathogens. Its "second genome" carries millions of genes versus roughly 20,000 human genes.

How does the microbiome connect to epigenetics?

Through butyrate. Besides fueling colon cells, butyrate is a histone-deacetylase (HDAC) inhibitor, shifting chromatin toward a more open, active state — a real epigenetic effect written by a molecule your bacteria made from fiber. It's the cleanest bridge from Day 75: microbes can influence how your own genes are read. Keep the claim modest — much evidence is from cell and model systems.

Do probiotics, "gut cleanses," or microbiome tests work?

Mostly the marketing runs ahead of the evidence. The AGA (2020) found insufficient evidence to recommend probiotics for most digestive conditions. "Gut reset"/"detox" is marketing, not physiology. Consumer microbiome tests are largely unvalidated and vary widely by lab (2025 analysis). The one proven microbiome therapy is FMT for recurrent C. difficile — specific, effective, and FDA-regulated.

Does Tesla BioLights make medical claims about this?

No. Zero medical claims. The microbiome is real and important — and it has exactly one clearly proven therapy, FMT for recurrent C. difficile, which is specific, effective, and regulated. That is precisely why "this probiotic or cleanse fixes everything" overreaches: most disease links are association, and consumer tests aren't validated diagnostics. Nothing here validates any product.

Bioelectric Mechanisms · The sacrifice · The countdown · The renewal · The memory · The ecosystem · Biofield Hub →

Tomorrow on the Journal

Day 77 — The Vagus Nerve: The Body's Great Wandering Cable. The gut talks to the brain, and the brain talks back, along a single wandering nerve that touches nearly every organ below the neck. Tomorrow: the anatomy of the vagus, the real physiology of the parasympathetic "rest and digest" state, "vagal tone" as a measurable thing — and where the wellness market's breathing gadgets and "nerve reset" claims part company with the evidence.

References

  1. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology. 2016;14(8):e1002533. DOI 10.1371/journal.pbio.1002533. PMID 27541692. (~38T bacteria, ~30T human cells, ~1:1, ~0.2 kg.) See also Sender, Fuchs, Milo, Cell. 2016;164:337–340, DOI 10.1016/j.cell.2016.01.013.
  2. Qin J, et al. (MetaHIT Consortium). A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. DOI 10.1038/nature08821. PMID 20203603. 3.3 million non-redundant microbial genes; ~1,000 gut bacterial species; the "second genome."
  3. Short-chain fatty acids & the epigenetic bridge. Chriett S, et al. Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor… Sci Rep. 2019 (PMC6346118). And "Human gut bacteria as potent class I HDAC inhibitors in vitro through production of butyric acid and valeric acid," PLoS One. 2018, DOI 10.1371/journal.pone.0201073. Butyrate fuels colonocytes and inhibits HDACs.
  4. Leeuwenhoek's "animalcules." Report to the Royal Society, 17 September 1683 (tooth-plaque bacteria), Phil. Trans. Context: Lane N. The unseen world: reflections on Leeuwenhoek (1677) "Concerning little animals." Phil Trans R Soc B. 2015;370:20140344. DOI 10.1098/rstb.2014.0344. ("Animalcules" is a standard translation.)
  5. van Nood E, et al. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415. DOI 10.1056/NEJMoa1205037. PMID 23323867. 81% resolution after one infusion vs. 31% (vancomycin); trial stopped early. Metchnikoff É. The Prolongation of Life: Optimistic Studies. 1907 (over-speculated). NIH Human Microbiome Project launched 2007: commonfund.nih.gov/hmp.
  6. FDA products, probiotics & consumer tests. Rebyota (fecal microbiota, live–jslm), first FDA-approved fecal microbiota product, 30 Nov 2022; Vowst (spores, live–brpk), first oral, 26 Apr 2023 (fda.gov). AGA Clinical Practice Guidelines on Probiotics, Gastroenterology. 2020, PMID 32531291 (insufficient evidence for most conditions). DTC microbiome-test performance: Communications Biology. 2025, DOI 10.1038/s42003-025-09301-3 (results vary widely; not diagnostics).
History of science · Documented · No medical claims · The ecosystem

The microbiome is real and vast — which is exactly why "reset your gut" overreaches.

It has exactly one clearly proven therapy — FMT for recurrent C. difficile — which is specific, matched to a defined infection, and regulated. That specificity is precisely why probiotic cure-alls, "gut cleanses," and consumer microbiome tests run ahead of the science: most disease links are association, not causation. The honest ledger keeps the proven biology, the frontier, and the overclaim apart. Tesla BioLights makes no medical claims and is validated by none of this.

Schedule a Session The Lineage
The Journal

One peer-reviewed essay per day

Leeuwenhoek, Metchnikoff, Milo, van Nood. Every name is documented. Every claim is cited — and every boundary is drawn.